Growth Metrics

Rigel Pharmaceuticals (RIGL) Shareholder's Equity Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 164.41%
Dec 31, 2025 213.30%
Sep 30, 2025 99.41%
Jun 30, 2025 189.58%
Mar 31, 2025 39.78%
Dec 31, 2024 -52.34%
Sep 30, 2024 -31.90%
Jun 30, 2024 -34.61%
Mar 31, 2024 -33.97%
Dec 31, 2023 -41.64%
Sep 30, 2023 -37.94%
Jun 30, 2023 -34.71%
Mar 31, 2023 -32.17%
Dec 31, 2022 -31.10%
Sep 30, 2022 -31.77%
Jun 30, 2022 -26.97%
Mar 31, 2022 -58.53%
Dec 31, 2021 -34.86%
Sep 30, 2021 -21.70%
Jun 30, 2021 -18.01%
Mar 31, 2021 -0.63%
Dec 31, 2020 -30.34%
Sep 30, 2020 -3.19%
Jun 30, 2020 -3.16%
Mar 31, 2020 -2.26%
Dec 31, 2019 -0.74%
Sep 30, 2019 1.48%
Jun 30, 2019 2.03%
Mar 31, 2019 8.10%
Dec 31, 2018 6.34%
Sep 30, 2018 2.39%
Jun 30, 2018 6.90%
Mar 31, 2018 -10.72%
Dec 31, 2017 -7.76%
Sep 30, 2017 -27.41%
Jun 30, 2017 -25.11%
Mar 31, 2017 -23.57%
Dec 31, 2016 -35.83%
Sep 30, 2016 -33.42%
Jun 30, 2016 -32.99%
Mar 31, 2016 -34.24%
Dec 31, 2015 -31.88%
Sep 30, 2015 -17.99%
Jun 30, 2015 -19.75%
Mar 31, 2015 -19.70%
Dec 31, 2014 -18.41%
Sep 30, 2014 -17.12%
Jun 30, 2014 -15.29%
Dec 31, 2013 7.82%